CERo Therapeutics Holdings, Inc.

CERO ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $42.4M

Liabilities Breakdown FY2022

Total Liabilities: $39.9M